» Articles » PMID: 33898478

Identify the Characteristics of Metabolic Syndrome and Non-obese Phenotype: Data Visualization and a Machine Learning Approach

Overview
Specialty General Medicine
Date 2021 Apr 26
PMID 33898478
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A third of the world's population is classified as having Metabolic Syndrome (MetS). Traditional diagnostic criteria for MetS are based on three or more of five components. However, the outcomes of patients with different combinations of specific metabolic components are undefined. It is challenging to be discovered and introduce treatment in advance for intervention, since the related research is still insufficient. This retrospective cohort study attempted to establish a method of visualizing metabolic components by using unsupervised machine learning and treemap technology to discover the relations between predicting factors and different metabolic components. Several supervised machine-learning models were used to explore significant predictors of MetS and to construct a powerful prediction model for preventive medicine. The random forest had the best performance with accuracy and c-statistic of 0.947 and 0.921, respectively, and found that body mass index, glycated hemoglobin, and controlled attenuation parameter (CAP) score were the optimal primary predictors of MetS. In treemap, high triglyceride level plus high fasting blood glucose or large waist circumference group had higher CAP scores (>260) than other groups. Moreover, 32.2% of patients with high CAP scores during 3 years of follow-up had metabolic diseases are observed. This reveals that the CAP score may be used for detecting MetS, especially for the non-obese MetS phenotype. Machine learning and data visualization can illustrate the complicated relationships between metabolic components and potential risk factors for MetS.

Citing Articles

Exploring Mortality and Prognostic Factors of Heart Failure with In-Hospital and Emergency Patients by Electronic Medical Records: A Machine Learning Approach.

Yu C, Wu J, Shih C, Chiu K, Chen Y, Chang T Risk Manag Healthc Policy. 2025; 18():77-93.

PMID: 39807211 PMC: 11727332. DOI: 10.2147/RMHP.S488159.


Enhanced Predictive Value of Lipid Accumulation Product for Identifying Metabolic Syndrome in the General Population of China.

Shao Q, Li J, Wu Y, Liu X, Wang N, Jiang Y Nutrients. 2023; 15(14).

PMID: 37513586 PMC: 10383986. DOI: 10.3390/nu15143168.


Exploring the Potential Performance of Fibroscan for Predicting and Evaluating Metabolic Syndrome using a Feature Selected Strategy of Machine Learning.

Chiu K, Chen Y, Wang S, Chang T, Wu J, Shih C Metabolites. 2023; 13(7).

PMID: 37512529 PMC: 10383149. DOI: 10.3390/metabo13070822.


"Big Data" Approaches for Prevention of the Metabolic Syndrome.

Jiang X, Yang Z, Wang S, Deng S Front Genet. 2022; 13:810152.

PMID: 35571045 PMC: 9095427. DOI: 10.3389/fgene.2022.810152.


Association between liver stiffness measurement by transient elastography and chronic kidney disease.

Chan Y, Chang S, Wu J, Wang S, Yu C Medicine (Baltimore). 2022; 101(4):e28658.

PMID: 35089208 PMC: 8797510. DOI: 10.1097/MD.0000000000028658.

References
1.
Mikolasevic I, Milic S, Turk Wensveen T, Grgic I, Jakopcic I, Stimac D . Nonalcoholic fatty liver disease - A multisystem disease?. World J Gastroenterol. 2016; 22(43):9488-9505. PMC: 5116593. DOI: 10.3748/wjg.v22.i43.9488. View

2.
Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K . The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005; 143(10):722-8. DOI: 10.7326/0003-4819-143-10-200511150-00009. View

3.
Lin Y, Lin C, Wang S, Lin S, Chang S . Noninvasive and Convenient Screening of Metabolic Syndrome Using the Controlled Attenuation Parameter Technology: An Evaluation Based on Self-Paid Health Examination Participants. J Clin Med. 2019; 8(11). PMC: 6912761. DOI: 10.3390/jcm8111775. View

4.
Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

5.
Byrne C, Targher G . NAFLD: a multisystem disease. J Hepatol. 2015; 62(1 Suppl):S47-64. DOI: 10.1016/j.jhep.2014.12.012. View